Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polymyalgia rheumatica revisited].

Pablo Przygoda1, Luis J Catoggio, Enrique R Soriano

  • 1Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Gascón 450, 1181 Buenos Aires, Argentina. pprzygoda@intramed.net.ar

Medicina
|September 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and histopathological predictors of systemic lupus erythematosus in a South American cohort of patients with full-house glomerulonephritis.

Lupus·2026
Same author

Incidence of Herpes Zoster in Patients With Rheumatoid Arthritis: Comparison With Controls and Risk According to Different Treatments.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same author

Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease.

The Journal of dermatology·2026
Same author

Neutrophil-to-Lymphocyte Ratio as a Predictor of Cardiovascular Events in Psoriatic Disease: A Retrospective Cohort Study.

ACR open rheumatology·2026
Same author

[REMI-ICAR: Argentine multicenter registry of hospitalization due to heart failure in medical clinic services].

Medicina·2026
Same author

Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study.

Annals of the rheumatic diseases·2026
Same journal

Detection of VIM-3 in oral squamous cell carcinomas: methodological limitations.

Medicina·2026
Same journal

The importance of specific antibodies in VIM-3 research: addressing a key methodological flaw.

Medicina·2026
Same journal

[From the right to be cared for to the duty to care: Legal bases for the implementation of palliative care in Argentina].

Medicina·2026
Same journal

[Surrogacy].

Medicina·2026
Same journal

[The misunderstandings in interpreting the "diagnostic superiority of Artificial Intelligence" and the explainable Artificial Intelligence].

Medicina·2026
Same journal

[Artificial intelligence in medicine: between algorithmic opacity and clinical responsibility].

Medicina·2026
See all related articles

Polymyalgia rheumatica (PMR) is an inflammatory condition causing muscle pain and stiffness in those over 50. Early diagnosis and corticosteroid treatment improve symptoms and function, with most patients discontinuing medication within 2 years.

Area of Science:

  • Rheumatology
  • Internal Medicine

Context:

  • Polymyalgia rheumatica (PMR) is an inflammatory disorder affecting individuals over 50.
  • Characterized by proximal muscle pain, stiffness, and elevated erythrocyte sedimentation rate (ESR).
  • PMR diagnosis is often one of exclusion, lacking universally accepted criteria.

Purpose:

  • To outline the diagnostic considerations and management of polymyalgia rheumatica.
  • To differentiate PMR from giant cell arteritis (GCA) and guide appropriate biopsy recommendations.
  • To emphasize the benefits of early diagnosis and low-dose corticosteroid therapy.

Summary:

  • PMR presents with characteristic symptoms and elevated ESR in older adults.
  • Diagnostic criteria for PMR are not universally established, necessitating exclusion of other conditions.

Related Experiment Videos

  • Temporal artery biopsy is not recommended for PMR patients without GCA symptoms.
  • Low-dose corticosteroids are effective in managing PMR symptoms and improving function.
  • Treatment duration typically ranges from 12 to 24 months, with a high rate of successful discontinuation.

    • Impact:

    • Facilitates earlier and more accurate diagnosis of polymyalgia rheumatica.
    • Guides clinicians in appropriate diagnostic workup, including when to avoid invasive procedures like temporal artery biopsy.
    • Highlights the efficacy and favorable long-term outcomes of low-dose corticosteroid treatment for PMR.
    • Improves patient quality of life and functional status through timely and effective management.